Data as of:
brimindinvest.com / compare / nvts-vs-aehrLIVE
NVTS
Navitas Semiconductor Corporation · Technology
$11.43
-10.91% this month
VERSUS
COMPARE
AEHR
Aehr Test Systems · Technology
$93.49
-13.40% this month
Comparison scoreboard
AEHR LEADS 5/5
AI Scorei
NVTS 22.7
AEHR 58.0
1Y Returni
NVTS +69.84%
AEHR +205.82%
Fwd P/Ei
NVTS -88.95
AEHR 68.45
Target Up.i
NVTS +25.56%
AEHR +35.18%
Op. Margini
NVTS -254.97%
AEHR -6.40%
Metrics last refreshed: 9/20/2026
Quick take

NVTS vs AEHR Stock Comparison: AI Score, Valuation, Performance and Upside

ShareXLinkedInRedditFacebookWhatsApp

NVTS and AEHR both benefit from wide-bandgap semiconductor adoption but from completely different positions in the value chain: NVTS sells GaN power ICs directly to end-market customers, while AEHR sells capital equipment used to test SiC devices during manufacturing. Both are small-cap, early-stage businesses with concentrated customer bases, but their revenue models and risk drivers are fundamentally different.

Choosing between NVTS and AEHR means choosing between a GaN device vendor with diversified end-market growth potential and an equipment maker with near-monopoly SiC burn-in exposure — both require SiC/GaN adoption to accelerate, but AEHR's success depends on fab capex cycles while NVTS depends on design-win conversion.

Live analysis · updated 9/20/2026

AEHR holds the edge across 5 of 5 key metrics in this comparison. AEHR leads on both 1-year return (+205.82%) and forward P/E quality (68.45x vs -88.95x for NVTS), a relatively favorable combination of momentum and valuation. AEHR leads on both revenue growth (33.70%) and operating margin (-6.40%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies meaningfully more upside for AEHR (+35.18%) than for NVTS (+25.56%).

Normalized 1Y performance
NVTS
AEHR
Recent returns
NVTS
AEHR
Analyst price targets & sentiment

Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.

NVTS
Price target range
analyst mean$14.08
current price$11.43
+25.6% upside to analyst mean
AEHR
Price target range
analyst mean$128.00
current price$93.49
+35.2% upside to analyst mean
Who should consider this stock?
NVTS may suit investors who:
  • prefer device-level exposure to GaN adoption in fast-growing end markets like EV charging
  • value an asset-light fabless model with scalable economics as design wins convert to revenue
  • want direct exposure to the transition from silicon to wide-bandgap semiconductors at the product level
  • are comfortable with pre-profitability status and consumer market revenue mix in the near term
AEHR may suit investors who:
  • prefer capital equipment exposure to SiC manufacturing capacity expansion with pricing power
  • value a near-monopoly equipment position backed by deep customer qualification cycles
  • want asymmetric upside from GaN burn-in adoption as a potential next catalyst
  • are comfortable with lumpy, order-driven revenue and concentration in the SiC device market
Performance & AI score
Performance & AI score
MetricNVTSAEHR
AI scorei22.758.0
AI ranki#4023#211
Latest closei$11.43$93.49
1M returni-10.91%-13.40%
6M returni+30.63%+170.83%
1Y returni+69.84%+205.82%
$10,000 invested — hypothetical growth (dividends reinvested)

How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?

$10,000 invested — hypothetical growth (dividends reinvested)
PeriodNVTSAEHR
1Y ago$16.98K (+69.8%)
started 2025-09-18
$30.58K (+205.8%)
started 2025-09-18
5Y ago$8.93K (-10.7%)
started 2021-10-20
$87.29K (+772.9%)
started 2021-09-20
10Y ago$8.93K (-10.7%)
started 2021-10-20
$434.84K (+4248.4%)
started 2016-09-19

Hypothetical — past performance does not guarantee future results.

Valuation & upside potential
Valuation & upside potential
MetricNVTSAEHR
Market capi$2.93B$3.09B
Trailing P/EiN/AN/A
Forward P/Ei-88.9568.45
Price/SalesiN/AN/A
EV/Revenuei63.0659.65
Analyst targeti$14.08$128.00
Target upsidei+25.56%+35.18%
Growth, profitability & risk
Growth, profitability & risk
MetricNVTSAEHR
Revenue growthi-27.30%33.70%
Earnings growthiN/AN/A
EPS growthiN/AN/A
FCF margini-10.44%-3.91%
Operating margini-254.97%-6.40%
Profit margini0.00%-14.25%
ROIC proxyi-52.60%-4.16%
Return on equityi-52.60%-4.16%
Dividend yieldiN/AN/A
Payout ratioi0.00%0.00%
Dividend growth streakiN/AN/A
Betai3.883.07
Debt/equityi0.644.50
Current ratioi21.7910.33
Quick ratioi20.347.60
Correlation

Over the past year, NVTS and AEHR have moved moderately in the same direction (correlation of 0.59), based on daily returns.

1Y
0.59
-1.0+1.0
5Y
0.39
-1.0+1.0
10Y
0.39
-1.0+1.0
Drawdown & downside risk

Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.

1Y risk snapshot
NVTS max drawdowni69.38%
AEHR max drawdowni47.62%
NVTS max wkly dropi41.75%
AEHR max wkly dropi33.78%
5Y risk snapshot
NVTS max drawdowni92.04%
AEHR max drawdowni87.37%
NVTS max wkly dropi41.75%
AEHR max wkly dropi36.64%
10Y risk snapshot
NVTS max drawdowni92.04%
AEHR max drawdowni87.37%
NVTS max wkly dropi41.75%
AEHR max wkly dropi43.32%
Performance metrics by period
Performance metrics by period
PeriodMetricNVTSAEHR
1YGrowthi+69.84%+205.82%
CAGRi+69.90%+206.06%
Volatilityi126.36%125.55%
Sharpe ratioi0.991.47
Sortino ratioi1.682.44
Max drawdowni69.38%47.62%
Current drawdowni64.05%35.79%
Avg drawdowni39.25%19.65%
Ulcer Indexi44.45%23.89%
Max daily dropi18.23%17.61%
Max wkly dropi41.75%33.78%
5YGrowthi-10.70%+772.92%
CAGRi-2.28%+54.32%
Volatilityi124.61%103.16%
Sharpe ratioi0.450.88
Sortino ratioi0.881.44
Max drawdowni92.04%87.37%
Current drawdowni64.05%35.79%
Avg drawdowni64.62%46.59%
Ulcer Indexi67.59%53.96%
Max daily dropi20.70%27.08%
Max wkly dropi41.75%36.64%
10YGrowthi-10.70%+4248.37%
CAGRi-2.28%+45.85%
Volatilityi124.61%95.94%
Sharpe ratioi0.450.80
Sortino ratioi0.881.37
Max drawdowni92.04%87.37%
Current drawdowni64.05%35.79%
Avg drawdowni64.62%49.13%
Ulcer Indexi67.59%54.84%
Max daily dropi20.70%27.08%
Max wkly dropi41.75%43.32%
AI Prediction Signali
Members only
Next 5 trading days
NVTS
+2.8%BUY
AEHR
+1.1%HOLD
Next 30 trading days
NVTS
+6.4%BUY
AEHR
+3.2%HOLD

Sign up to unlock AI price predictions

ML model trained on historical prices · 14-day free trial · No credit card required
Business comparison
Business comparison
CategoryNVTSAEHR
CompanyNavitas Semiconductor CorporationAehr Test Systems
SectorTechnologyTechnology
IndustrySemiconductorsSemiconductor Equipment & Materials
Core businessNavitas designs GaN power ICs for EV chargers, mobile fast chargers, data center power supplies, and solar inverters. Its fabless model and monolithic GaN integration differentiate it from discrete component suppliers. Revenue is scaling from consumer origins toward higher-value automotive and data center markets.Aehr Test Systems designs wafer-level burn-in and test systems used to screen out early-life failures in silicon carbide (SiC) and silicon power devices. Its FOX-XP and FOX-NP systems allow semiconductor manufacturers to stress-test SiC MOSFETs at the wafer level before dicing, catching infant mortality defects that would otherwise cause field failures in EVs. Aehr is the dominant supplier of wafer-level SiC burn-in equipment to major SiC device makers.
Investor focusInvestors track design-win momentum in EV and data center segments, the timeline to profitability, and gross margin expansion as the product mix shifts toward higher-ASP industrial applications.Investors focus on SiC burn-in equipment order flow from major customers (Wolfspeed, onsemi, STMicro, Infineon), revenue visibility from multi-system orders tied to new fab openings, and whether gallium nitride (GaN) device makers begin adopting wafer-level burn-in—a potential next market expansion.
NVTS strengths
  • Proprietary GaNFast technology integrates GaN FET with gate driver and protection, reducing system complexity
  • Strong early position in GaN for 800V EV on-board chargers and DC fast-charge station power supplies
  • Fabless structure allows R&D focus without the capital burden of manufacturing
AEHR strengths
  • Near-monopoly on wafer-level SiC burn-in equipment, driven by patented FOX architecture and customer qualification cycles
  • Orders tied to fab expansion decisions at major SiC manufacturers, providing multi-quarter revenue visibility
  • GaN burn-in is an emerging potential market that could expand the total addressable market significantly
Risks to watch — NVTS
  • Consumer and mobile revenue still dominates the mix, creating smartphone-cycle vulnerability
  • Path to profitability requires significant revenue scaling that depends on EV and data center design-win conversion
  • Multiple larger competitors have announced GaN product roadmaps targeting the same markets
Risks to watch — AEHR
  • Revenue is highly concentrated in SiC burn-in; a slowdown in SiC fab capex directly hits orders
  • Customer order timing is lumpy, making quarterly revenue volatile and difficult to model
  • A competitor winning a major SiC customer qualification could significantly disrupt market position
Frequently asked questions
Both companies are high-risk, high-potential-reward bets on wide-bandgap semiconductor adoption, making the choice primarily about which risk profile fits the investor. AEHR's near-monopoly in SiC wafer burn-in provides a strong competitive moat, but revenue is lumpy and tied to fab capex cycles. NVTS's GaN ICs address multiple growing end markets, but the company faces more competition and is further from profitability. Neither is appropriate for risk-averse investors.
Free public comparison

Want deeper AI forecasts?

This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.

Related comparisons
More comparisons
Browse all 1,000 comparisons
ShareXLinkedInRedditFacebookWhatsApp